Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00872_DB04946 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00872_DB04946 label "DDI between Conivaptan and Iloperidone - CYP3A4 Inhibitors (Strong) may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolites P88 and P95 may be increased. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Iloperidone. Reduce iloperidone dose by half when administered with a strong CYP3A4 inhibitor. [drugbank_resource:DB00872_DB04946]" assertion.
- drugbank_resource:DB00872_DB04946 identifier "drugbank_resource:DB00872_DB04946" assertion.
- drugbank_resource:DB00872_DB04946 title "DDI between Conivaptan and Iloperidone - CYP3A4 Inhibitors (Strong) may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolites P88 and P95 may be increased. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Iloperidone. Reduce iloperidone dose by half when administered with a strong CYP3A4 inhibitor." assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB04946 assertion.
- drugbank:DB04946 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB04946 assertion.